Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Generex, Immuron, Karyopharm, Molecular Partners, Neoimmunetech, Orchard, Orphazyme, Osmotica, Sanifit, Sorrento.

Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Albireo, Alexion, Can-Fite, Contrafect, Cytocom, Enlivex, Epsilogen, Geneuro, Imquest, Innovation, Inozyme, JW Therapeutics, Kedrion, Mateon, Metaclipse, PTC Therapeutics, Santhera, Sonnet, Vaxil.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Abbvie, Amplyx, Arcutis, Ascletis, Astrazeneca, Basilea, Bergenbio, Bioniz, Biontech, Bioxcel, Connect, Exelixis, Lantern, Pfizer, Synairgen, Vertex.

Biopharmas raising money in public or private financings, including: Annexon, Azurrx, Freeline, Frequency, Genix, Inozyme, Iteos, Magicmed, Nurix, Oncternal, Outlook, Processa.

New hires and promotions in the biopharma industry, including: Akcea, Dyne, Immunogen, IMV, Kronos, Rhythm, SQZ, Tenax.

Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Ambu, Bristol-Myers Squibb.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Nucleix.

Med-tech firms raising money in public or private financings, including: Curadigm, Deerfield Healthcare Technology Acquisitions, Genetic Technologies.

Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Beigene, BMS, Botanix, Denovo, Nabriva, Puma, Specialised Therapeutics, Sunovion.

Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Applied DNA, Aptorum, Bio-Thera, Curadigm, Cyclerion, Fairhaven, Liminal, Ocular, Orphazyme, Pharmapark, Takis.